# Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

> **NCT05715944** · PHASE3 · COMPLETED · sponsor: **Botswana Harvard AIDS Institute Partnership** · enrollment: 10888 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** AZD 1222

## Key facts

- **NCT ID:** NCT05715944
- **Lead sponsor:** Botswana Harvard AIDS Institute Partnership
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-15
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 10888 (ACTUAL)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05715944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05715944, "Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05715944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*